Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Navigating 2026 Pharma Trends: What Drug Discovery Leaders Need to Know Now

    August 31, 2026

    Navigating 2025-2030 Dietary Guidelines for Metabolic Health Challenges

    August 30, 2026

    Struggling to Track Rapid Medical Research Advances? Key 2025 Trial Outcomes for Your Practice

    August 28, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Health Magazine
    • Home
    • Environmental Health
    • Health Technology
    • Medical Research
    • Mental Health
    • Nutrition Science
    • Pharma
    • Public Health
    • Discover
      • Daily Health Tips
      • Financial Health & Stability
      • Holistic Health & Wellness
      • Mental Health
      • Nutrition & Dietary Trends
      • Professional & Personal Growth
    • Our Mission
    Health Magazine
    Home » News » Oral antibiotics after discharge have no effect on pediatric appendicitis
    Discover

    Oral antibiotics after discharge have no effect on pediatric appendicitis

    healthadminBy healthadminJune 1, 2026No Comments3 Mins Read
    Oral antibiotics after discharge have no effect on pediatric appendicitis
    Share
    Facebook Twitter Reddit Telegram Pinterest Email



    Acute appendicitis is one of the most common surgical emergencies among children, and complicated acute appendicitis (CAA), including perforation or gangrenous disease, carries a high risk of infection and prolonged hospital stay. Although intravenous antibiotics during hospitalization are standard treatment, the role of home oral antibiotics (OHA) after discharge remains controversial. Many hospitals continue home oral antibiotics (OHA) to prevent late-onset infections, but this practice varies by surgeon and facility. At the same time, unnecessary antibiotic exposure can cause side effects, disrupt gut flora, and increase the risk of infections. clostridioides difficile It causes infections and contributes to antimicrobial resistance. These concerns have prompted calls for stronger evidence about the real-world value of post-discharge antibiotics for children with CAA.

    Researchers from the Department of Pediatric Surgery, Complejo Asistencial de Leon University, Spain, and Pediatric Surgery, Niño Jesús University Hospital, Madrid, Spain, published their findings online. World Pediatric Journal January 27, 2026 (DOI: 10.1007/s12519-025-01008-z). This study evaluated whether post-discharge OHA reduces infectious complications and readmission compared to non-home antibiotics (NHA) in children treated surgically for CAA.

    The researchers searched PubMed, Web of Science, Scopus, Ovid, and Cochrane Central from database inception until March 2025, and the reviews were prospectively registered in the International Prospective Register of Systematic Reviews (PROSPERO). Fourteen observational studies involving 26,174 pediatric patients were included. Importantly, no randomized controlled trials (RCTs) were identified, highlighting the limited strength of evidence currently available. A random effects meta-analysis was conducted for intra-abdominal abscess (IAA), surgical site infection (SSI), OSI, and readmission.

    Across pooled analyses, OHA did not significantly reduce the risk of IAA, OSI, or readmission. The pooled risk ratios were 1.23 for IAA, 1.19 for OSI, and 1.07 for readmission, with 95% confidence intervals all above the null threshold. Although SSI appeared to be lower in the OHA group in the overall analysis, this signal disappeared in sensitivity analyzes restricted to studies using crude patient-level exposure data, suggesting that protocol differences and confounding may have shaped the results. Exposure limitation analysis showed that children discharged without antibiotics had a slightly lower risk of readmission, suggesting possible harm from routine OHA.

    The authors stated that these findings should not be interpreted as a call to abandon clinical judgment, but as evidence that automatic continuation of antibiotics after discharge requires stronger justification. They said the review shows a consistent gap between common practice and proven benefits. Children with CAA are often given antibiotics and sent home because they are at risk for the disease, but the available evidence does not show a reliable reduction in major complications. They also emphasized that the certainty of the evidence remains very low, primarily because the included studies were all observational and susceptible to confounding by indication.

    This study supports a more selective, evidence-based approach to post-discharge care of children with CAA. For hospitals, the results can inform antibiotic stewardship programs, discharge pathways, and shared decision-making with families. Reducing unnecessary OHAs, combined with clear discharge criteria and follow-up plans, may help reduce medication burden, limit adverse events, and address antimicrobial resistance without compromising recovery. However, the authors emphasize that high-quality multicenter RCTs are urgently needed to determine which children truly benefit from antibiotics after hospital discharge. Until then, the routine use of OHA after surgery for pediatric CAA is not supported by current evidence.

    sauce:

    Chinese Academy of Sciences

    Reference magazines:

    Arredondo Montero, J., Rico Jiménez, M. (2026). Home oral antibiotic use after discharge in complicated pediatric appendicitis: a systematic review and meta-analysis. World Journal of Pediatrics. DOI: 10.1007/s12519-025-01008-z. https://link.springer.com/article/10.1007/s12519-025-01008-z



    Source link

    Visited 12 times, 1 visit(s) today
    Share. Facebook Twitter Pinterest LinkedIn Telegram Reddit Email
    Previous ArticleModerate to vigorous physical activity promotes mental health in midlife more than walking
    Next Article Cleveland Clinic and Aspira begin collaboration on women’s health
    healthadmin

    Related Posts

    Texas A&M researchers build AI tool for tuberculosis drug discovery

    July 30, 2026

    New ultrasound technology breaks blood-brain barrier to treat gliomas

    July 30, 2026

    Omalizumab wins multi-allergen oral immunotherapy in multi-food allergy trial

    July 30, 2026

    MAGFLO™ NGS beads: cost-effective nucleic acid purification

    July 30, 2026

    Qureight completes $20 million Series B funding

    July 30, 2026

    Cigarette smoke extract stimulates airway cells and increases nanoplastic damage

    July 30, 2026
    Add A Comment

    Comments are closed.

    Categories

    • Daily Health Tips
    • Discover
    • Environmental Health
    • Exercise & Fitness
    • Featured
    • Featured Videos
    • Financial Health & Stability
    • Fitness
    • Fitness Updates
    • Health
    • Health Technology
    • Healthy Aging
    • Healthy Living
    • Holistic Healing
    • Holistic Health & Wellness
    • Medical Research
    • Medical Research & Insights
    • Mental Health
    • Mental Wellness
    • Natural Remedies
    • New Workouts
    • Nutrition
    • Nutrition & Dietary Trends
    • Nutrition & Superfoods
    • Nutrition Science
    • Pharma
    • Preventive Healthcare
    • Professional & Personal Growth
    • Public Health
    • Public Health & Awareness
    • Selected
    • Sleep & Recovery
    • Top Programs
    • Weight Management
    • Workouts
    Popular Posts
    • 1773313737_bacteria_-_Sebastian_Kaulitzki_46826fb7971649bfaca04a9b4cef3309-620x480.jpgHow Sino Biological ProPure™ redefines ultra-low… March 12, 2026
    • pexels-david-bartus-442116The food industry needs to act now to cut greenhouse… January 2, 2022
    • 1773729862_TagImage-3347-458389964760995353448-620x480.jpgDespite safety concerns, parents underestimate the… March 17, 2026
    • 1774403998_image_28620e4b6b0047f7ab9154b41d739db1-620x480.jpgGait pattern helps distinguish between Lewy body… March 24, 2026
    • 1773209206_futuristic_techno_design_on_background_of_supercomputer_data_center_-_Image_-_Timofeev_Vladimir_M1_4.jpegMulti-agent AI systems outperform single models… March 11, 2026
    • Leukemia-620x480.jpgBiomimetic platform powers CAR T therapy for… March 9, 2026

    Demo
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Navigating 2026 Pharma Trends: What Drug Discovery Leaders Need to Know Now

    By healthadminAugust 31, 2026

    Explore key 2026 biopharma trends in AI-driven discovery, regulatory shifts, manufacturing, and FDA approvals for pharmacologists and executives.

    Navigating 2025-2030 Dietary Guidelines for Metabolic Health Challenges

    August 30, 2026

    Struggling to Track Rapid Medical Research Advances? Key 2025 Trial Outcomes for Your Practice

    August 28, 2026

    The Future of Digital Health: Telemedicine, Wearables, and AI Diagnostics

    August 27, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    HealthxMagazine
    HealthxMagazine

    At HealthX Magazine, we are dedicated to empowering entrepreneurs, doctors, chiropractors, healthcare professionals, personal trainers, executives, thought leaders, and anyone striving for optimal health.

    Our Picks

    The Future of Digital Health: Telemedicine, Wearables, and AI Diagnostics

    August 27, 2026

    Why Health Tech Founders and Engineers Face Urgent Pressure in 2026

    August 26, 2026

    Navigating the Flood of 2025-2026 Clinical Trial Data

    August 24, 2026
    New Comments
      Facebook X (Twitter) Instagram Pinterest
      • Home
      • Privacy Policy
      • Our Mission
      © 2026 ThemeSphere. Designed by ThemeSphere.

      Type above and press Enter to search. Press Esc to cancel.